Self Assembled RSV Nanoparticle Vaccines

The present invention provides nanoparticles and compositions of various constructs that combine meta-stable viral proteins (e.g., RSV F protein) and self-assembling molecules (e.g., ferritin, HSPs) such that the pre-fusion conformational state of these key viral proteins is preserved (and locked) along with the protein self-assembling into a polyhedral shape, thereby creating nanoparticles that are effective vaccine agents. The invention also provides nanoparticles comprising a viral fusion protein, or fragment or variant thereof, and a self-assembling molecule, and immunogenic and vaccine compositions including the same.

Researchers

Vidya Subramanian / Aditya Raguram / Ram Sasisekharan

Departments: School of Engineering
Technology Areas: Chemicals & Materials: Nanotechnology & Nanomaterials / Therapeutics: Vaccines
Impact Areas: Healthy Living

  • self assembled rsv nanoparticle vaccines
    Hong Kong | Pending

License this technology

Interested in this technology? Connect with our experienced licensing team to initiate the process.

Sign up for technology updates

Sign up now to receive the latest updates on cutting-edge technologies and innovations.

More Technologies